title: Inhibition of SGLT2: a novel strategy for treatment of type 2 diabetes mellitus.
authors.affiliation: Bristol-Myers Squibb Research and Development, Princeton, New Jersey, USA.
authors.forename: M
authors.initials: M
authors.lastname: Pfister
authors.forename: J M
authors.initials: JM
authors.lastname: Whaley
authors.forename: L
authors.initials: L
authors.lastname: Zhang
authors.forename: J F
authors.initials: JF
authors.lastname: List
mesh_terms: D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000503:physiopathology; D015195:Drug Design; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D023421:Models, Animal; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors
chemical_list: D007004:Hypoglycemic Agents; C089180:SLC5A2 protein, human; D051297:Sodium-Glucose Transporter 2; D000077203:Sodium-Glucose Transporter 2 Inhibitors; D005947:Glucose